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mccording  to  the  International  Continence  Society  (ICS),  uri-
ary  incontinence  (UI)  is  deﬁned  as  the  involuntary  passing
f  urine  through  the  urethra.  It  is  estimated  that  over  200
illion  people  in  the  world  suffer  from  this  condition;  a
urvey  conducted  in  2002  in  different  countries  found  a
I  prevalence  of  34%  in  Germany,  compared  with  15%  in
pain.  The  elderly  have  a  signiﬁcant  increased  tendency
f  this  problem.  Calculations  have  shown  that  11.8%  of
eople  between  the  ages  of  40  and  44  may  suffer  from
his  illness,  compared  to  27.6%  of  people  between  60  and
4,  occurring  more  frequently  in  females  than  males  at  a
:2  ratio.
In  order  to  better  understand  the  causes  of  incontinence
t  is  important  to  comprehend  the  physiology  of  the  lower
rinary  tract.  The  bladder  performs  two  functions:  to  store
nd  empty  urine.  In  order  to  store  urine  it  is  necessary
o  have  a  competent  sphincter  and  a  distensible  detrusor
uscle.  This  means  that  both  the  internal  sphincter  and
xternal  sphincter  must  have  greater  pressure  in  relation
o  the  detrusor.  As  the  bladder  is  ﬁlling  up,  propriocep-
ive  endings  of  the  vegetative  system  send  impulses  toward
he  brain,  speciﬁcally  the  frontal  lobe,  where  the  sense  of
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ends  inhibitor  signals  to  the  spinal  cord  segment  S2--S4
reventing  the  exit  of  urine.  When  the  bladder  is  full,
 disinhibition  reﬂex  occurs;  this  disinhibition  produces  a
ecrease  in  the  sphincter’s  pressure  and  a detrusor  contrac-
ion,  resulting  in  urination.  Urinary  incontinence  can  be
aused  by  mechanical  problems  like  loss  of  sphincter  pres-
ure  or  reduction  in  bladder  distensibility,  or  neurological
ffects  like  those  caused  by  spinal  trauma,  diabetes  mel-
itus  or  any  other  neuropathy  which  affects  the  urination
echanism.
There  are  several  types  of  UI:
Stress  incontinence  (also  known  as  effort  incontinence):
When  there  is  a sudden  change  in  intra-abdominal  pres-
sure  and  the  sphincter  is  not  capable  of  controlling  bladder
pressure.
Urge  incontinence  (also  known  as  hyperactive  bladder):  it
occurs  due  to  a  loss  of  control  of  the  inhibitor  reﬂex  toward
the  bladder,  producing  an  urge  to  urinate.
Mixed  incontinence:  observed  in  patients  with  stress  incon-
tinence  combined  with  urge  incontinence.
Overﬂow  incontinence:  Not  being  able  to  efﬁciently  empty
the  bladder,  thus  having  an  ‘‘overﬂow’’  with  an  involuntary
loss  of  urine.
Functional  incontinence:  in  patients  with  ambulation  alter-
ations,  and  who  do  not  present  any  abnormality  in  bladder
functioning.
asson Doyma México S.A. All rights reserved.
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Reﬂex  incontinence:  in  patients  with  a  neuropathy  explain-
ing  the  loss  of  urine  control.
When  examining  a  UI  patient  we  must  ask  directed  ques-
tions,  focusing  on  the  causes  predisposing  the  incontinence,
differentiate  the  type  of  UI,  as  well  as  ﬁnd  out  the  level
of  incontinence.  For  example:  whether  or  not  the  patient
uses  a  protector,  and  if  so,  the  type  and  number  of  pro-
tectors,  since  the  extent  and  severity  of  the  UI  will  not
be  the  same  if  the  patient  uses  a  pad  as  a  protector,  as
opposed  to  the  severity  of  the  patient  who  wears  a  diaper.
After  the  thorough  interrogation  documenting  the  patient’s
history  and  the  evolution  of  the  urinary  pathology,  we  will
proceed  to  perform  physical  examinations,  corroborating
inﬂammatory  alterations  on  the  skin  around  the  genital  area
because  of  the  constant  urination.  We  must  observe  if  there
are  any  ambulation  alterations  or  the  impossibility  of  walk-
ing,  as  well  as  examine  the  anal  tone,  if  there  is  a  voluntary
anus  contraction  and  if  there  is  presence  of  bulbocavernosus
reﬂex,  this  examination  is  vital  since  it  will  inform  us  about
the  integrity  of  the  pudendal  nerve.
Among  the  basic  studies  there  is  the  urine  analysis  test
and  urine  culture,  in  order  to  rule  out  the  most  frequent
transitory  cause  of  incontinence,  which  is  urinary  infection.
Over  the  years,  and  having  a  signiﬁcant  functional  blad-
der  alteration,  this  tends  to  produce  deterioration  in  renal
functions  with  the  possibility  of  developing  hydronephrosis
and/or  pyelonephritis.  We  should  also  consider  the  possibil-
ity  of  developing  lithiasis  in  the  urinary  tract.  In  women,  we
must  consider  assessing  the  level  of  cystocele  or  urethro-
cele,  requesting  the  patient  to  push  and  observing  whether
or  not  there  is  a  loss  of  urine  in  the  process.  Once  these
parameters  are  reviewed,  and  having  diagnosed  the  type  of
UI,  we  ought  to  offer  the  proper  treatment.  If  we  diagnose
stress  incontinence,  we  will  assess  if  the  patient  is  a  candi-
date  for  pelvic  ﬂoor  rehabilitation  or  a  surgical  procedure
(urethral  suspension  or  pelvic  prolapse  repair).
In  the  case  of  urge  incontinence,  by  discarding  urinary
infection  and  without  neurogenic  data  which  explains  it,
the  initial  approach  must  be  made  with  an  anticholinergic
medication.  If  the  response  is  positive,  continue  with  the
anticholinergic  for  a  period  of  3--4  months,  after  this  period
we  should  stop  the  medication  and  assess  if  the  vesical  func-
tion  has  normalized.  In  the  case  that  there  is  no  an  adequate
control  a  urodynamic  study  (the  golden  standard  for  bladder
neurofunctional  evaluation)  must  be  performed.  This  study
determines  different  parameters:  intravesical,  urethral  and
abdominal  pressure.  Moreover,  an  electromyography  must
be  performed,  in  the  storage  period  as  well  as  the  vesical
emptying  stage,  to  try  to  reproduce  the  mechanism  by  which
the  incontinence  occurs  as  a  way  to  understand  and  assess
the  problem.
When  we  think  a  neurogenic  origin  is  the  cause  of  incon-
tinence,  it  is  necessary  to  assess  the  patient’s  neurological
history  which  may  explain  it.  If  it  is  not  documented  it  is
not  possible  to  rule  out  this  possibility,  since  between  3%
and  12%  of  the  patients  with  a  neurological  problem  begin
with  signs  of  UI.  When  inspecting  the  patient  with  a  sus-
pected  functional  bladder  alteration,  the  urodynamic  study
will  help  with  the  diagnosis  of  the  type  of  neurogenic  blad-
der,  evaluating  the  possibility  of  upper  urinary  tract  damage.
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ubsequent  urodynamic  studies  will  reveal  whether  or  not
here  was  a  response  to  treatment.
There  are  a  variety  of  UI  treatments:  (a)  medical,  (b)
ehabilitation  and  (c)  surgical.
a)  Medical  treatments  include  the  use  of  anticholinergics
like  oxybutynin  vs  tolterodine.  Currently,  beta-3  adreno-
ceptors,  like  Mirabegron  (which  is  not  sold  in  Mexico)
are  used  to  reduce  the  detrusor  muscle  pressure  and
increase  vesical  capacity.  Tricyclic  antidepressants  like
imipramine  help  improve  the  contraction  strength  of
the  external  sphincter  and  reduce  stress  urinary  incon-
tinence  periods.
b)  Rehabilitation  treatments  using  Kegel  exercises,  where
the  patient  is  shown  how  to  contract  and  strengthen  the
perineum  musculature.  These  are  useful  in  the  handling
of  stress  incontinence  in  women  with  pelvic  ﬂoor  pro-
lapse,  as  well  as  in  prostatectomized  men.  It  has  been
shown  that  only  40%  of  the  patients  perform  the  exer-
cises  correctly,  most  contract  the  abdomen  instead  of
the  perineum  which  worsens  the  symptoms.  With  proper
guidance  and  training,  we  can  help  patients  perform
these  exercises  correctly.  Perineum  electrostimulation
can  also  be  used  in  order  to  improve  muscle  tone,  or
posterior  tibial  nerve  stimulation  for  a  better  managing
of  urge  incontinence.
c)  Surgical  treatments  include  the  application  of  botulinum
toxin  (botox)  at  the  sphincter  level  to  reduce  its  pres-
sure  in  patients  with  extremely  high  pressures.  It  is  also
used  with  patients  who  do  not  respond  adequately  to
anticholinergics.  This  toxin  contributes  to  the  reduction
of  intravesical  pressure  and  improves  storage  capa-
bilities.  An  anesthetic  sedation  is  necessary  for  the
application  of  botox,  and  the  introduction  of  a  cysto-
scope  to  inﬁltrate  the  muscular  layer  of  the  bladder.
In  some  UI  patients  who  do  not  respond  adequately  or
have  a  severe  incontinence  level,  the  use  of  urethral
tapes  and  slings  at  a  urethral  level  may  help  control
involuntary  loss  of  urine.  Patients  who  do  not  improve
their  vesical  capacity  with  any  of  these  interventions  can
undergo  an  augmentation  cystoplasty,  which  consists  of
the  use  of  an  intestinal  patch  to  increase  distention  sur-
face,  thus  increasing  the  capacity  and  reducing  vesical
pressure,  which  would  be  the  last  line  in  the  manage-
ment  of  capacity  and  intravesical  improvement.  Those
patients  with  an  intrinsic  sphincter  deﬁciency  can  be
closed  with  a  sling  or  tape  on  the  urethra  to  produce
an  obstruction,  which  will  have  to  be  managed  with
intermittent  catheterization.  Also,  there  is  the  artiﬁ-
cial  sphincter,  a  surgical  procedure  with  application  of
a  prosthesis  with  a  urethral  cuff.  When  pumped  (at
scrotum  level  or  in  the  vulva’s  labia  majora),  the  cuff
empties  and  the  release  of  urine  occurs.
Neuromodulation  consists  of  placing  electrodes  in  the
acral  nerve  roots,  which  go  to  an  internal  computer  sys-
em,  which  regulates  and  modulates  the  stimuli  which  occur
n  the  bladder,  improving  urinary  storage  and  emptying,  as
ell  as  controlling  the  possible  pain  that  the  patient  may
ave.
Once  we  have  assessed  the  patient,  made  the  correct
iagnosis  and  offered  the  proper  treatment,  it  is  important
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o  give  follow-up  to  prevent  complications,  improve  self-
steem  and  avoid  social  stigmatization.
After  ruling  out  correctable  causes  like  urinary  infection,
esicoureteral  reﬂux  and  hydronephrosis,  if  the  patient’s
ymptoms  persist,  it  is  important  to  refer  him/her  to  a  spe-
ialist  with  experience  in  the  management  and  treatment  of
hese  type  of  pathology,  considering  that  the  main  cause  of
orbi-mortality  in  patients  with  neurogenic  bladder  is  renal
ailure.
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